BA
65
2
DOW
36
-2
AON
34
2
ALLE
35
-2
EOG
36
2
MRK
25
-5
PCG
56
-2
DFS
71
4
TSN
32
-3
HAL
41
2
TXN
35
2
F
40
-3
EQR
40
-2
RHI
59
2
ESS
59
2
FFIV
70
3
ISRG
71
3
TDC
86
2
MAT
43
2
A
41
-3
BA
65
2
DOW
36
-2
AON
34
2
ALLE
35
-2
EOG
36
2
MRK
25
-5
PCG
56
-2
DFS
71
4
TSN
32
-3
HAL
41
2
TXN
35
2
F
40
-3
EQR
40
-2
RHI
59
2
ESS
59
2
FFIV
70
3
ISRG
71
3
TDC
86
2
MAT
43
2
A
41
-3
Financhill
Back

BlueScope Steel 10K Form

Sell
47

BLSFF
BlueScope Steel

Last Price:
13.50
Seasonality Move:
-4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLSFF News And Ratings

See the #1 stock for the next 7 days that we like better than BLSFF

BLSFF Financial Statistics

Sales & Book Value

Annual Sales: $11.15B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $16.32
Price / Book: 0.83

Profitability

EPS (TTM): 1.17030
Net Income (TTM): $527.63M
Gross Margin: $4.35B
Return on Equity: 7.07%
Return on Assets: 5.04%

BlueScope Steel Earnings Forecast

Key BlueScope Steel Financial Ratios

  • The Gross Profit Margin over the past 23 years for BLSFF is 38.99%.
  • The Selling, General & Administrative Expenses for BLSFF have been equal to 19.22% of Gross Profit Margin.
  • The Research & Development expenses have been 0.20% of Revenue.
  • The Interest Expense is 4.11% of Operating Income.
  • The Net Earning history of BLSFF is 4.74% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

BlueScope Steel Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Metals & Mining
Sector: Materials
Current Symbol: BLSFF
Website: bluescope.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.97
Quick Ratio: 0.87

Price-to-Earnings

Trailing P/E Ratio: 11.52
Forward P/E Ratio: 0

BLSFF Technical Analysis vs Fundamental Analysis

Sell
47
BlueScope Steel (BLSFF) is a Sell

Is BlueScope Steel a Buy or a Sell?

  • BlueScope Steel stock is rated a Sell
    The current BlueScope Steel [BLSFF] share price is $13.50. The Score for BLSFF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.